Dave stock price target raised to $300 from $280 at Citizens JMP

Published 26/09/2025, 10:12
Dave stock price target raised to $300 from $280 at Citizens JMP

Investing.com - Citizens JMP raised its price target on Dave Inc (NASDAQ:DAVE) to $300 from $280 while maintaining a Market Outperform rating. The company, which has seen its stock surge over 450% in the past year according to InvestingPro data, continues to demonstrate strong momentum with a "GREAT" overall financial health score.

The firm cited Dave’s strong earnings revisions that have outpaced the stock’s recent performance, noting the company still trades at an enterprise value to 2026 estimated adjusted EBITDA multiple of approximately 13.5x. This outlook is supported by impressive revenue growth of 48% and a healthy gross profit margin of 67% in the last twelve months.

Citizens JMP increased its 2025 adjusted EBITDA estimate to $190 million from $185 million and its 2026 estimate to $233 million from $219 million, positioning its forecast about 6% above consensus for 2026.

The firm highlighted Dave’s projected growth trajectory, with estimated EBITDA growth of 118% in 2025 and 23% in 2026, which it believes can support a multiple "at least in the mid-to-upper teens."

For comparison, Citizens JMP noted that Dave’s closest public competitor, Chime (CHYM), currently trades at approximately 28x 2026 estimated EBITDA, suggesting potential valuation upside for Dave shares.

In other recent news, Dave Inc. reported second-quarter 2025 results that exceeded expectations, leading the company to raise its full-year guidance. Freedom Capital Markets responded by increasing its price target for Dave to $280, maintaining a Buy rating. Additionally, Benchmark reiterated its Buy rating with a $320 price target, emphasizing that Dave’s margins remain unaffected by JPMorgan Chase’s new data aggregator charging policy.

In a strategic move, Dave announced the full implementation of CashAI v5.5, an upgraded version of its cash flow underwriting engine, enhancing credit access and performance. The company has also increased its share repurchase authorization to $125 million, replacing the previous $50 million authorization. Since the second-quarter earnings report, Dave has deployed approximately $25 million for stock repurchases.

Year-to-date, the company has invested over $45 million in share repurchases and RSU net settlements. These developments reflect Dave’s ongoing efforts to strengthen its financial position and product offerings.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.